Literature DB >> 11085282

Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms?

A D Blann1.   

Abstract

The loss of well-regulated endothelial cell functioning is followed by adverse changes in a variety of physiological systems, such as the expression of adhesion molecules, maintenance of adequate blood vessel tone and haemostasis. Therefore, a full understanding of endothelial cell biology is essential if the losses of normal function of these systems are to be avoided. The viewpoint presented in this paper suggests that a spectrum between endothelial cell health and disease can be drawn: midway between these two extremes is immunological activation (by, for example, cytokines), which is reversible. Endothelial cell damage or injury (which may be the result of chronic inflammatory activation, hypercholesterolaemia, and/or smoking) are invariably associated with clinical conditions such as hypertension and oedema (and, ultimately, thrombosis and infarction), and are more difficult to reverse. A better understanding of the events, including apoptosis, that lead to vascular dysfunction may be useful in developing our understanding of vascular biology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085282     DOI: 10.1097/00001721-200010000-00006

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  25 in total

Review 1.  Biomarkers and HIV-associated cardiovascular disease.

Authors:  Jason V Baker; Daniel Duprez
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 2.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

3.  Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent.

Authors:  Lei Feng; Beverly A Kienitz; Carolyn Matsumoto; Jeffrey Bruce; Michael Sisti; Hoang Duong; John Pile-Spellman
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

4.  Heat shock protein 70, heat shock protein 32, and vascular endothelial growth factor production and their effects on lipopolysaccharide-induced apoptosis in porcine aortic endothelial cells.

Authors:  Chiara Bernardini; Augusta Zannoni; Maria Elena Turba; Paolo Fantinati; Carlo Tamanini; Maria Laura Bacci; Monica Forni
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

5.  Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure.

Authors:  Judit Czúcz; László Cervenak; Zsolt Förhécz; Tímea Gombos; Zoltán Pozsonyi; Jan Kunde; István Karádi; Lívia Jánoskuti; Zoltán Prohászka
Journal:  Clin Res Cardiol       Date:  2011-02-11       Impact factor: 5.460

6.  Recombinant erythropoietin down-regulates IL-6 and CXCR4 genes in TNF-alpha-treated primary cultures of human microvascular endothelial cells: implications for multiple sclerosis.

Authors:  Jagannadha R Avasarala; Sastry S Konduru
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  Caloric restriction: powerful protection for the aging heart and vasculature.

Authors:  Edward P Weiss; Luigi Fontana
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-12       Impact factor: 4.733

8.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

Review 9.  The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.

Authors:  Jason V Baker; W Keith Henry; James D Neaton
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

10.  Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices.

Authors:  Qi Da; Miho Teruya; Prasenjit Guchhait; Jun Teruya; John S Olson; Miguel A Cruz
Journal:  Blood       Date:  2015-08-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.